Moderna May 5, 2026 Boston biotech firms back new effort to preserve U.S. edge in life sciences - The Business Journals
Moderna May 4, 2026 Vertex drops Moderna-partnered inhaled cystic fibrosis candidate after unresolved tolerability issues - Fierce Biotech
Moderna May 4, 2026 Biopharma bites: Tolerability sinks Vertex-Moderna's CF candidate, Takeda's immune win, and more from Amgen, Latus - FirstWord Pharma
Moderna May 1, 2026 Moderna sees revenue bump from international COVID vaccine sales - BioPharma Dive
Moderna Apr 30, 2026 Moderna loses key mRNA patent in European vaccine fight - Life Sciences Intellectual Property Review
Moderna Apr 28, 2026 Moderna Deploys Salesforce Agentforce Life Sciences to Unify Global Commercial Operations - HIT Consultant
Moderna Apr 28, 2026 CureVac targets Moderna with 10-patent suit over Spikevax - Life Sciences Intellectual Property Review
Moderna Apr 22, 2026 Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trial - BioPharma Dive
Moderna Apr 22, 2026 Moderna launches mRNA bird flu vaccine trial after HHS cancels funding - The Washington Post
Moderna Apr 21, 2026 Moderna | History, Innovation, Challenges, & Facts | Britannica Money - Britannica
PharmaVoice Mar 31, 2026 mRNA is poised to rise beyond infectious diseases, if it’s not derailed by R&D cuts
eLife Mar 23, 2026 Dynamic regulation of mRNA acetylation at synapses by spatial memory in mouse hippocampus
eLife Mar 20, 2026 Competition for the conserved branch point sequence influences physiological outcomes in pre-mRNA splicing